Dr. Ellen Vigdorth has 25+ years of drug development experience, leading clinical programs in allergy, respiratory, vaccine, and anti-infective agents.

Dr. Ellen Vigdorth has more than 25 years of drug development experience, spanning investigative research sites, global pharmaceutical companies, and contract research organizations (CROs). She has led clinical development programs across a range of therapeutic indications, including allergy, respiratory, vaccine and anti-infective agents. Ellen spent more than 20 years in various roles at IQVIA (formerly Quintiles). Initially trained as a microbiologist, she holds a PhD in infectious disease epidemiology from the University of Cincinnati College of Medicine.

Dr. Ellen Vigdorth has more than 25 years of drug development experience. She has led clinical development programs across a range of therapeutic indications. Ellen spent more than 20 years in various roles at IQVIA (formerly Quintiles). Initially trained as a microbiologist, she holds a PhD in infectious disease epidemiology from the University of Cincinnati College of Medicine.